title: Tissue engineered tracheal prosthesis with acceleratedly cultured homologous chondrocytes as an alternative of tracheal reconstruction.
abstract: BACKGROUND
  Autologous tissue is an ideal substitue for an extensive tracheal reconstruction, but it is rarely feasible in clinical situations. Many tracheal prosthesis had been used for such an instances, but unfortunately it is still problematic. Dislocation, local infection, hemorrage, and luminal stenosis can cause prosthetic failure. To achieve clinically available autologous tracheal prosthesis, it is necessary that we have to get phenotypically functioning chondrocytes, rapid differentiation of harvested autologous chondrocytes, and the survival of free grafted cultured chondrocytes.
  
  
  METHODS
  In this study, we investigated isolation and culture method of the chondrocytes using the rabbit costal cartilage, and the cells were characterized microscopically and biochemically first. Then we have used cultured rabbit chondrocytes to investigate the role of growth factors upon the proliferation and regulation of the cultured chondrocytes. We have examined the effect of peptide growth factors on DNA and proteoglycan synthesis to the rabbit chondrocyte. The effects of IGF-I and basic FGF were investigated individually. Secondly, acceleratedly cultured chondrocytes were embeded to polymer (PLGA) scaffold in bioreactor, and implanted to defected rabbit trachea. Six weeks later, the rabbits were sacrificed and examined their histologic characteristics.
  
  
  RESULTS
  The harvested chondrocytes from costal arch grew well and were amplified successfully maitaining their own phenotypes. Its embedding to PLGA scaffold was accomplished successfully. The implanted tracheal prosthesis maintains its physical integrity well, but the histologic examination revealed non-viable chondrocytes. The epithelial linings were good.
  
  
  CONCLUSIONS
  The tissue engineered tracheal prosthesis can be a promising alternative of good functional air way tube in short term experiment, but biologically not vital yet. Further investigations are necessary to see the survival of free grafted chondrocytes and the long term results.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Paldalgu, Suwon, Korea. cjlee@madang.ajou.ac.kr
authors.forename: C J
authors.initials: CJ
authors.lastname: Lee
authors.forename: K D
authors.initials: KD
authors.lastname: Moon
authors.forename: H
authors.initials: H
authors.lastname: Choi
authors.forename: J I
authors.initials: JI
authors.lastname: Woo
authors.forename: B H
authors.initials: BH
authors.lastname: Min
authors.forename: K B
authors.initials: KB
authors.lastname: Lee
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects / Q000378:metabolism / Q000637:transplantation*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006133:Growth Substances / Q000494:pharmacology; D010641:Phenotype; D011108:Polymers; D019736:Prostheses and Implants; D011817:Rabbits; D013997:Time Factors; D023822:Tissue Engineering; D014132:Trachea / Q000601:surgery*
chemical_list: D006133:Growth Substances; D011108:Polymers